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As was indicated in my initial Editor’s Page, the state of
health of JACC is excellent as the new Editors assume
responsibility for the Journal. Judged by any criteria, the
Journal is extremely successful and plays a central role in the
professional life of most cardiovascular specialists. Given
this status, it follows that any changes to the Journal should
be implemented carefully and only after due consideration.
In the process of transition of the Editorial Office, however,
a number of new initiatives were considered that clearly
seemed to warrant early implementation. This Editor’s Page
will be devoted to describing these early initiatives.
THE PARMLEY PRIZE
In recognition of the outstanding contributions that my
predecessor, Bill Parmley, made to JACC, Elsevier Science
Inc. has generously established an award that we have
designated “The Parmley Prize.” Although not all of the
details have been finalized, it is important that authors,
potential authors, and Program Directors be aware of this
award. The Parmley Prize is intended to recognize two
outstanding papers published in JACC by primary authors
who are young investigators. The award is meant to honor
not only the young investigator but also the program in
which he or she is working. The award itself will consist of
certificates for both the awardees and their Program Direc-
tors, as well as grants to cover the expenses for awardees to
attend the Annual Scientific Sessions or an educational
program of the American College of Cardiology (ACC).
The presentation of the Parmley Prize will take place at the
annual meeting of the JACC Editorial Board at the Scien-
tific Sessions.
Currently, plans call for the Editor and Associate Editors
to select the manuscript published by a young investigator in
any given year which best fulfills the standard criteria for
acceptance for publication. These criteria include original-
ity, methodology, presentation, and importance. The defi-
nition of “young investigator” is, of course, subject to
considerable individual interpretation. For the purpose of
this award, a “young investigator” will be designated as one
who is within five years of having completed the training
requirements for specialty Board Certification or PhD
degree. We plan to introduce an inquiry space into the
submission form in order to identify candidates from among
the authors submitting manuscripts. However, it will be
important for Program Directors and colleagues to nomi-
nate and identify individuals who are eligible for the award.
They can do so by writing, faxing, or e-mailing me at the
JACC Editorial Office in San Diego. Because the announce-
ment of the award is coming in mid-year, we have declared
all papers published since January of 2002 eligible for
consideration.
As evidenced by the well established Young Investigator
Awards program, the ACC has long recognized the impor-
tance of fostering junior researchers. Publication in a com-
petitive peer review scientific journal represents the culmi-
nation of a successful research project. By acknowledging
the excellence of the research performed, we at the ACC
and at JACC hope that this award will further support young
investigators and the programs that nurture them. Any
additional positive impact on the Journal will, of course, also
be warmly welcomed.
It was the intention of the ACC and Elsevier that the
Parmley Prize pay homage to the efforts and accomplish-
ments of Bill Parmley as Editor of JACC. By lending his
name to this effort, Bill bestows a special honor on the
award and provides an exceptional role model for young
scientists both as investigators and human beings. We
anticipate that the Parmley Prize will become a widely
sought-after and acknowledged award—one for which po-
tential candidates are aggressively identified and encouraged
by their superiors and peers.
Express Pubs and Expedited Reviews
The recent extraordinary advances in communications have
markedly accelerated the transmission of new knowledge
and information. In the field of medical journals, rapid
transmission has taken the form of expedited on-line
electronic processing of submitted manuscripts, and it is also
being accomplished by the institution of protocols for
accelerated review and publication. Although special proto-
cols have probably been implemented by editors and authors
on a case-by-case basis for some time, we are now formal-
izing these pathways and inviting submissions to them when
appropriate. Specifically, JACC has now established two
alternate pathways of manuscript submission: Express Pubs
and Expedited Reviews.
Express Pubs represent manuscripts that contain highly
original information of immediate and significant impor-
tance to clinical care or research endeavors. Many aspects of
these new observations may not be fully defined, such as
underlying mechanisms or actual clinical significance; how-
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ever, the observations themselves are of sufficient impact to
warrant accelerated publication. Since these papers will
typically not represent a complete exposition of the subject,
it is anticipated that they will be readily accommodated by
the reduced 2,500-word limitation we have established for
this category. For Express Pubs, the Editors will commit to
an initial decision within 14 days of receiving a manuscript,
on-line publication in JACC within 10 days, and publication
in the printed Journal within six weeks.
The category of publication designated as Expedited
Reviews includes those full-length manuscripts that share
with Express Pubs the timeliness and importance to either
clinical care or research. These manuscripts will contain
information that should immediately influence patient man-
agement or the direction of investigational efforts. It is
anticipated that only select manuscripts will fulfill these
requirements. Therefore, the Editors commit to a decision
within five days of receiving the paper as to whether a
manuscript submitted in this category warrants such pro-
cessing and, if selected, commit to an initial decision within
14 days. Manuscripts accepted by this pathway will be
published on-line in JACC within 10 days and in print in the
Journal within six weeks.
Express Pubs and Expedited Reviews provide a mecha-
nism for JACC to provide new data to the cardiovascular
community as quickly as possible. They represent our
attempt to deal with the competing priorities of rapid
transmission of information and complete delineation of
methods and results in such a manner that the data can be
appropriately evaluated and adopted by the readers. We
recognize that either a delay in publication of important new
data or a transmission of incomplete or inadequately de-
scribed data has equal limitations. The existing review and
publication process has worked very well to achieve com-
pleteness for many years. It is hoped that these new
approaches will address the problem of delayed publication
of important findings.
Viewpoints
Papers not dealing with original research findings have
typically appeared in JACC either as state-of-the-art reviews
or as editorial comments related to specific manuscripts.
Similarly, standard protocol at medical meetings has called
for presentations to consist of either the description of new
research findings or a review of existing information. Re-
cently, several meetings have instituted sessions inviting
presentations of strongly held opinions, even when they are
not based on specific research findings. These talks have
typically dealt with subjects that the presenter felt passion-
ately about, have usually engendered considerable discus-
sion, and have become among the most highly attended
venues of the meetings.
We believe that the considered and strongly held opin-
ions of thoughtful individuals could make a significant
contribution to JACC. We anticipate that these pieces will
often be provocative and, hopefully, will stimulate consid-
erable thought and interchange. Such papers may raise
questions rather than provide answers, but they are also
likely to stimulate the pursuit of resolution.
We have elected to use the term “Viewpoints” for this
category of manuscript submission. Papers submitted to
Viewpoints may deal with any aspect relevant to cardiovas-
cular medicine and must be limited to 1,000 words. In
general, these papers should deal with broad-based issues;
opinion pieces directed toward highly focused topics may be
more appropriate for a point-counterpoint type of presen-
tation. As with all other manuscripts submitted to JACC,
Viewpoints will be judged on their originality, presentation,
and relevance, as well as on the conviction with which they
are presented.
The Parmley Prize, Express Pubs and Expedited Re-
views, and Viewpoints are initiatives that should enhance
the strength and impact of JACC. They have been struc-
tured to extend the excellence of the original clinical and
experimental research manuscripts, editorials, and reviews
that constitute the core of the Journal. In addition to
honoring Dr. Parmley, it is our hope that these early
initiatives will provide benefits to both authors and readers.
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